Co-mutations in surgically resected and EGFR mutated lung adenocarcinoma: A subset analysis of the large prospective cohort study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e20520
Abstract: e20520Background: Several studies including LUX LUNG 3 and 6 have shown that there are biological differences between EGFR exon 19 deletions (del19) and exon 21 L858R mutation (L858R) in lung adeno... read more here.
Keywords: surgically resected; egfr mutated; mutated lung; mutations surgically ... See more keywords
Efficacy of adjuvant EGFR inhibitors and impact of clinical factors in resected EGFR-mutated non-small-cell lung cancer: a meta-analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2021-0934
Abstract: Background: The role of adjuvant EGFR tyrosine kinase inhibitors (TKIs) in resected EGFR-mutated non-small-cell lung cancer (NSCLC) remains unclear. Materials & methods: We evaluated pooled hazard ratio and 95% CI for disease-free survival, overall survival and… read more here.
Keywords: non small; survival; resected egfr; adjuvant egfr ... See more keywords